Abstract

There has been great progress in ocular gene therapy, but delivery of viral vectors to the retinal pigmented epithelium (RPE) and retina can be challenging. Subretinal injection, the preferred route of delivery for most applications, requires a surgical procedure that has risks. Herein we report a novel gene therapy delivery approach, suprachoroidal injection of AAV8 vectors, which is less invasive and could be done in an outpatient setting. Two weeks after suprachoroidal injection of AAV8.GFP in rats, GFP fluorescence covered 18.9% of RPE flat mounts and extended entirely around sagittal and transverse sections in RPE and photoreceptors. After 2 suprachoroidal injections of AAV8.GFP, GFP fluorescence covered 30.5% of RPE flat mounts. Similarly, widespread expression of GFP occurred in nonhuman primate and pig eyes after suprachoroidal injection of AAV8.GFP. Compared with subretinal injection in rats of RGX-314, an AAV8 vector expressing an anti-VEGF Fab, suprachoroidal injection of the same dose of RGX-314 resulted in similar expression of anti-VEGF Fab and similar suppression of VEGF-induced vascular leakage. Suprachoroidal AAV8 vector injection provides a noninvasive outpatient procedure to obtain widespread transgene expression in retina and RPE.

Guidelines:
The Editorial Board will only consider letters that we deem relevant and of interest to our readers. We
will not post data that have not been subjected to peer review, nor will we post letters that are
essentially a reiteration of another letter. We reserve the right to edit any letter for length, content, and clarity.
Authors will be notified by e-mail if their letters were accepted. No appeals will be considered.

Specific requirements: All letters must be 400 words or fewer. You may enter the letter as plain
text or HTML. The author's name and e-mail address are required, and will be posted with the letter. All
possible conflicts of interest must be noted, even if they are not posted. If you wish to include a
figure (keep in mind that non-peer-reviewed data will not be posted), please contact the editors
directly at editors@the-jci.org.

First nameThis field is required

Last nameThis field is required

PositionThis field is required

InstitutionThis field is required

Email addressThis field is required

Other authors (Enter the list of colleagues in the following form: Stephanie Fulton, Thomas L. Wilding, and Frances Groen.)